FW
ABBV icon

Fairway Wealth’s AbbVie ABBV Stock Holding History

Fairway Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3K Buy
+45
New +$9.68K ﹤0.01% 177
2025
Q3 		– Sell
-55
Closed -$10.2K – 158
2025
Q2 		$10.2K Hold
55
– – ﹤0.01% 125
2025
Q1 		$11.5K Sell
55
-345
-86% -$67.1K ﹤0.01% 156
2024
Q4 		$71.1K Buy
+400
New +$73.5K 0.03% 85
2024
Q3 		– Sell
-150
Closed -$25.7K – 101
2024
Q2 		$25.7K Buy
+150
New +$24.8K 0.02% 84

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fairway Wealth's ABBV Position: Q2 2026 in Review

Fairway Wealth opened a new position in AbbVie (ABBV) in Q2 2026: 45 shares worth $11.3K. The stake represents ﹤0.01% of the portfolio and ranks #177 among its holdings. This is a return to the name: Fairway Wealth previously reported a position in ABBV as recently as Q2 2025.

Fairway Wealth first reported a position in ABBV in Q2 2024 and has held it in 5 quarters since. The position peaked at $71.1K in Q4 2024. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fairway Wealth held 45 shares of AbbVie worth $11.3K as of Q2 2026.
  • AbbVie was a new Fairway Wealth position in Q2 2026.
  • AbbVie made up ﹤0.01% of Fairway Wealth's portfolio in Q2 2026, its #177 holding.
  • Fairway Wealth first reported a position in AbbVie in Q2 2024 and has held it in 5 quarters since.
  • Fairway Wealth's AbbVie position peaked at $71.1K in Q4 2024.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fairway Wealth's 13F filing for Q2 2026, filed 24 Jul 2026.